An online presentation by Danielle Gunn-Moore, Professor of Feline Medicine at the Royal (Dick) School of Veterinary Studies in Edinburgh, has been launched by Dechra Veterinary Products as part of its Dechra Academy training suite.
During the presentation, Professor Gunn-Moore uses a case study approach to discuss all aspects of the condition from diagnosis through to its treatment, management and on-going monitoring. She reminds viewers that an individual approach must be taken in treating affected cats as the clinical signs can be subtle and starting treatment with the lowest possible dose of anti-thyroid medication is likely to prove physiologically beneficial.
"The study I've recently been involved in showed that the treatment of hyperthyroid cats can result in iatrogenic hypothyroidism*. Hypothyroid cats are significantly more likely to develop azotaemia than euthyroid cats - and hypothyroid cats that developed azotaemia in the study had significantly shorter survival times*.
"The message for practitioners is that there is no 'standard recipe' in treating hyperthyroidism. The clinical signs aren't always obvious and it's important to check for concurrent heart and kidney disease. You then need to tailor treatment, starting with a low dose of medication and, if necessary, increasing it by the smallest increments possible."
To watch Professor Gunn-Moore's presentation, visit www.dechra.co.uk/hyperthyroidism.
Reference:* Williams, T. et al (2010) JVIM 24: 1086-1092
The company says the return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare and generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, said: “With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Up to date information on the brands and their distribution can be found on the Vetoquinol website, www.vetoquinol.co.uk, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
For this study, researchers in Argentina, Italy, Austria and Chile, set out to evaluate the efficacy of and adverse events from the administration of ACEIs to treat preclinical MMVD in dogs, via a systematic review of published evidence conducted according to the Cochrane Handbook for Systematic Reviews of Interventions.
Certainty of evidence was assessed using the GRADE (https://gradepro.org) approach.
The main finding in relation to dogs with preclinical MMVD and cardiomegaly was backed by a high certainty of evidence. The certainty of evidence in relation to the efficacy of ACEI administration in dogs without cardiomegaly was low.
Dr Pablo Donati, corresponding author for the paper, said: “In recent times, multiple clinical trials have provided fundamental information to veterinary cardiology.
"In the era of evidence-based medicine, systematic reviews and meta-analyses have emerged as a fundamental tool for clinical decision-making by gathering, appraising and summarizing the best available evidence.
"It is the hope of the authors that this systematic review and meta-analysis helps in the decision-making process for the treatment of preclinical myxomatous mitral disease with angiotensin-converting enzyme inhibitors in dogs.”
Nicola Di Girolamo, Editor of JSAP, added: “In line with other leading journals, the JSAP is prioritizing the publication of methodologically sound systematic reviews such as this one.
"However, our readers should be aware that the findings of systematic reviews should always be considered in light of their internal validity, i.e. the quality of the included studies, and their external validity, i.e. the generalizability of the included studied to the individual patient.”
Reference
Donati, P., Tarducci, A., Zanatta, R., Verdier, N., Belerenian, G., Cordero, I., Villalta, C., Franco, J. and Tarragona, L. (2022), Angiotensin-converting enzyme inhibitors in preclinical myxomatous mitral valve disease in dogs: systematic review and meta-analysis. J Small Anim Pract. https://doi.org/10.1111/jsap.13461
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
Mark Colonnese, Aquarium’s Sales and Marketing Director said: "As someone who owns two dogs, the results of the survey have not come as too much of a surprise to me, but I know that some of my colleagues were pretty surprised just how important we think our pets are."
The survey showed that the feelings were even stronger among women, 71% of whom would regard a pet death as equally upsetting to that of a family member’s, compared to 55% of men.
Mark added: "Our results really highlight the sensitivity of issues surrounding a pet’s death. While this would be obvious to, for instance, a life insurance company, our survey reinforces the need for an empathetic customer journey among pet insurers. The first step of this process is ensuring a smooth, seamless process to minimise stress for newly bereaved pet parents."
Cystease® S, CEVA Animal Health's urinary tract support product for cats, is now available in a new 100 tablet pack size for greater convenience to the practice.
CEVA`s small animal veterinary advisor Fraser Broadfoot said: "Previously Cystease® S was only available in 300 tablet packs. The new 100 tablet pack size makes the product easier to store in the practice and easier to dispense to clients."
To help vets gain easy access to information on Feline Lower Urinary Tract Disease (FLUTD), CEVA Animal Health have also produced a highly informative technical review on the subject. Produced in conjunction with Professor Danielle Gunn-Moore, head of the feline clinic at the University of Edinburgh, the eight-page, colour brochure contains practical information on the clinical signs, diagnosis and treatment of FLUTD and also includes behavioural advice on reducing stress in cats, which can be a major cause of FLUTD.
To receive a free copy of CEVA's FLUTD technical review and for further information on Cystease® S, please contact Fraser Broadfoot MRCVS on 01494 781510, CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
Equine infectious anaemia (EIA) has been detected in a horse in Northumberland following importation from the Netherlands, Defra confirmed today.
The premises is currently under restriction and the infected horse will be humanely destroyed in line with existing regulations. The other horses on the premises are currently subject to epidemiological investigation.
The horse arrived in a group of six horses originating in the Netherlands and all have been tested for EIA as part of routine post-import testing. The other five horses in the group have all tested negative.
Chief Veterinary Officer Nigel Gibbens said: "This again shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy this horse."
Meanwhile, equine welfare charity World Horse Welfare is sending out an urgent plea to all horse owners across the UK and mainland Europe to work together in order to stop the increasing threat from this and a number of other diseases.
According to the charity, this case comes only eight months after the discovery of two horses suffering from the disease, which is notifiable, in Wiltshire. Those horses had been transported across Europe from Romania before being imported into the UK. Since the end of August alone, there have been new outbreaks reported in Northern France (directly linked to horses imported from Romania), the Dordogne area, and Germany.
World Horse Welfare Chief Executive Roly Owers said: "While World Horse Welfare welcomes the news that Defra has acted so promptly in dealing with this case, today's news is extremely concerning and demonstrates the changing environment we're living in. This is a real warning to us that we're sailing far too close to the wind. The concerning question is where these horses came from given that Holland to date has not reported a case of EIA.
"With more and more horses moving across Europe, including the significant trade in low value animals, not just slaughter animals, we're facing an increasing threat from the spread of disease. EIA is endemic in both Romania and Italy; Romania being one of the largest exporters and Italy being the largest importer of horses for slaughter in Europe. In spite of the legal requirement for health certification before exporting horses from Romania, which were tightened in June 2010, there continues to be cases of EIA across Europe.
"World Horse Welfare advises owners to undertake rigorous checks when buying a horse from abroad and is discouraging anyone from importing Romanian horses. Owners should also ensure that any horse they buy or that comes on to their yard has a passport, is checked for a microchip and that isolation and biosecurity measures are strictly followed for any new entry onto the yard. If this disease spreads across the UK it could have catastrophic effects on our horse population. Whether it's a child's pony or Cheltenham Gold Cup winner, disease does not discriminate."
Compliance with equine medicines legislation involves the challenges of food production, equine passport and essential medicines legislation as well as the prescribing Cascade, VMD guidance and the RCVS practice standards scheme.
With these in mind, the online guidance now includes:
The BEVA says the new medicines guidance resource has already been invaluable for members working towards the new Practice Standards Scheme, such as Josh Slater from the RVC, who said: "The PSS Awards define what a high-functioning equine practice looks like. The BEVA medicines guidance documents enabled us to fulfil the PSS Awards scheme requirements for demonstrating responsible use of medicines and compliance with requirements such as Cascade prescribing and emergency treatment of horses, helping us to achieve our Outstanding rating in the PSS Awards. The resource will be very useful for all equine practices preparing for PSS inspections and continues to be an invaluable day-to-day reference source for us."
The BEVA will also be holding two equine medicine courses in October 2017, providing evidence-based updates on a range of topical issues in equine medicine. The focus will be on recent research with practical relevance and the courses are aimed at clinicians who have attained or are working towards certificate level qualifications. The first will be held in Oulton, Leeds on 10 October and the second in Oxford on 31 October.
Dr Crespo appeared in front of the Disciplinary Committee earlier this week with two charges against her. The first was that, in November 2015, she dishonestly and falsely made an online representation to the College that she had no criminal convictions, cautions or adverse findings despite having been convicted, in January 2015, of failing to provide a specimen of breath. The second charge against her was that, in March 2016, she once again dishonestly and falsely failed to declare her conviction when renewing her registration.
During the hearing the Committee had two main considerations in respect of both charges – as to whether Dr Marin Crespo had been dishonest in failing to declare the conviction and as to whether the respondent ought to have known that her representations were false. Regarding the dishonesty element, the Committee found the College had not sufficiently proven this, as it accepted Dr Marin Crespo’s evidence that she did not believe she needed to declare a motoring-related offence as it was not relevant to her professional practice.
However, the Committee found it proven that the respondent ought to have known that the representations were false, taking into account that Dr Marin Crespo made admissions that she ought to have checked the guidance on declaring convictions, cautions and/or adverse findings and ought to have been aware that making such declarations is a requirement of the RCVS Code of Professional Conduct.
Having found the parts of the two charges relating to false representation proven, the Committee then considered whether this constituted serious professional misconduct.
Judith Webb, chairing the Committee and speaking on its behalf, said:"The Committee considers that the false declarations made by the respondent were born of a careless disregard for the disclosure process. The Committee notes that the respondent could easily have checked online, and/or by telephone, as to what she was obliged to do when making the relevant declarations. She failed to do that.
"In these circumstances, the Committee considers that the respondent’s conduct fell far short of that which is to be expected of the veterinary profession. Therefore, in the judgement of the Committee, on the facts found proved, the respondent is guilty of disgraceful conduct in a professional respect."
In considering Dr Marin Crespo’s sanction the Committee took into account a number of mitigating factors including her full cooperation with the College’s investigation, her hitherto unblemished career, her testimonial evidence which it felt demonstrated her dedication and professionalism, and the fact that she has displayed remorse and insight into her conduct.
Judith Webb concluded: "The Committee notes that the respondent’s conduct caused no harm, or risk of harm, to animals or humans. The Committee also notes that there is no charge arising out of the criminal conviction itself. The Committee considers that, if the respondent had answered the online questions correctly, it is unlikely that the respondent would have appeared before the Committee.
"Every veterinary surgeon must ensure that they adopt a careful and accurate approach to the self-certification exercise, which is crucial if the public and the College are to have trust in that process. In these circumstances, the Committee considered that the proportionate sanction in this case is that the respondent be… reprimanded for her conduct."
The British Safety Council has launched a new qualification to help people who drive as part of their work stay safe on the roads.
According to the organisation, the Level 2 Award in Safe Driving at Work provides work drivers with key knowledge of the hazards and risks associated with driving and equips them with valuable guidance on the measures available for reducing these risks, such as vehicle inspection, behaviour and defensive driving.
According to estimates from the Health and Safety Executive (HSE), up to a third of all road traffic accidents in Britain involve someone involved in work-related activity. In 2013, according to government figures, 1,713 people died on the road, with the total number of casualties standing at 183,670.
The Ofqual-regulated qualification, which is designed to be delivered by employers or training organisations, instructs learners on a range of topics including the particular risks associated with vulnerable road users, such as cyclists and pedestrians, the importance of regular vehicle safety checks and how to adapt driving style in response to changes in driving conditions or the actions of others.
Alex Botha, the British Safety Council's Chief Executive, said: "Driving can be a risky activity, a fact borne out by the high number of injuries and fatalities that occur annually on our roads.
"However, simple steps can be taken by employers and drivers to manage and reduce this risk. Our new Level 2 Award in Safe Driving at Work provides learners with all the essential knowledge to help them stay safe on the roads.
"Learners can expect to leave the qualification with a thorough knowledge of the main risks posed by driving - whether to themselves or other road users - and how to reduce them.
"Once registered with us, employers or training centres deliver the training using the high-quality teaching and student materials provided. Qualifications are assessed through a 45-minute multiple-choice examination that can be either taken online or on paper.
"This is a stand-alone qualification designed for delivery as a short course. It is also well-suited for integration into wider vocational programmes of study or, for example, as part of an induction programme. Students need no former knowledge or experience, so can come from a diverse range of educational and employment backgrounds.
"Safer driving habits should also feed through into workers' personal lives, providing employers with a valuable corporate social responsibility tool to help make our roads safer in and out of work."
Dechra Veterinary Products (maker of Cardisure) has launched a new online CPD course which consists of a series of short presentations about treating congestive heart failure in dogs, developed with cardiology consultant Mike Martin.
According to the company, approximately 10% of dogs presented to first opinion practices have heart disease. The majority of cases are suffering with myxomatous mitral valve disease (MMVD) or, less commonly, dilated cardiomyopathy (DCM).
Mike said: "This is a series of short presentations with audio, that covers the common challenges, issues and questions that we all encounter in clinical practice. Aimed squarely at the very busy practitioner, this 'piece by piece' course will help you differentiate between cardiac and respiratory cases, update you on the current ACVIM guidelines on the treatment of heart failure in dogs and how best to monitor your patient in the short to long term. It's been a fun series to put together with the help of Dechra – enjoy."
Craig Sankey, Business Manager for Cardiology at Dechra said: "This series of bite-sized videos highlight the importance of diagnosing, treating and monitoring congestive heart failure in dogs in an interactive e-learning environment, topped with quizzes and drag and drops to test ones knowledge.
"Furthermore, the beauty of this format means Veterinary Professionals can dip in and out of each section depending on the area they need to build their expertise, without the pressure of completing the whole course all at once’.
The course equates to one hour CPD and can be found on the Dechra Academy: https://academy.dechra.com/learn/course/external/view/elearning/718/cardiology-piece-by-piece
More information about Cardisure can be found at www.dechra.co.uk/Cardisure
The VetGDP, which replaced the Professional Development Phase (PDP), provides a period of structured support to aid the transition of newly-registered veterinary surgeons from veterinary studies to life in the workplace.
VetGDP is being rolled out during 2021 and this year’s veterinary graduates will need to enrol on it.
One of the main features of VetGDP is the requirement for a trained VetGDP Adviser to be available in the practice to provide their new graduate with one-to-one, meaningful support and guidance, to help develop their confidence and capabilities.
In order for veterinary surgeons to become VetGDP Advisers they must complete an online training package being developed by the RCVS and formally commit to supporting new graduates.
Practices that have trained VetGDP Advisers and make this commitment will receive the status of an RCVS-Approved Graduate Development Practice.
The original plan was that practices who wish to employ this year’s cohort of graduates should have obtained RCVS-Approved Graduate Development Practice status by June 2021.
This has now been amended in recognition of the additional pressures that veterinary practice teams are under as a result of the pandemic.
Practices who employ graduates this year will now have until December 2021 to achieve this status, provided they have started to work towards RCVS-Approved Graduate Development Practice status and commit to supporting their new graduate while they do so.
Dr Linda Prescott-Clements, RCVS Director of Education, said: “The ongoing pandemic restrictions, specifically changes made by the government to veterinary professionals’ key worker status on 13 January, means that there are now significant additional pressures on practice teams, particularly in terms of staffing, as many members of the profession will be balancing their work with caring responsibilities. We recognise this and, as such, we have updated the timeframe for the completion of our training for VetGDP Advisers.
“I would also like to personally thank the 850 vets who have already registered their interest in becoming VetGDP Advisers. It is very reassuring to see so many members of the profession committed to supporting new members of the profession, and wanting to engage with the training and with VetGDP to help nurture and develop our future vets through their first few years in practice.”
The College will be holding three VetGDP workshops in February. Each workshop will feature the same content, so there’s no need to attend more than one.
They take place on:
The workshops are open to anyone in the veterinary team including veterinary surgeons who may be considering becoming a VetGDP Adviser, practice managers and others involved in graduate recruitment and anyone else who would like to find out more about VetGDP.
The sessions will be interactive and there will be a significant portion of time given over to Q&As. The RCVS Chair of Education Committee, Dr Sue Paterson FRCVS, and Dr Linda Prescott-Clements, will be available to answer any questions which can be submitted live during the event. You can also submit questions as you register for the workshop at: www.rcvs.org.uk/vetgdpworkshops.
For more information, visit: www.rcvs.org.uk/vetgdp
Newmarket-based Test and Treat was one of three finalists, for its U-Treat test which enables vets to diagnose a UTI and get antibiotic sensitivity results in an hour.
Rachel Kirkby MRCVS, Business Development Director at Test and Treat, said: "It’s a great accolade to be recognised by such a prestigious award. The Vet Record Innovation Award celebrates new innovations that can bring about improvement and make a real difference to vets in practice – and that’s exactly what we’re aiming to do with U-Treat.”
The second finalist was the Animal Welfare Assessment Grid, developed by Public Health England (PHE), in collaboration with the University of Surrey School of Veterinary Medicine. Initially developed in zoos, rescue and research centres, there are plans now to develop it for use in small animal practice and in the farm sector.
The overall winner was PBD Biotech for Actiphage, its test for bTB and Johne's disease which gives very early detection, thereby allowing vets and farmers to prevent the spread of infection.
For more information, visit: https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.267
The company says the product improves oral health in three ways: cleaning teeth, freshening breath, and helping to reduce the formation of new plaque and tartar.
The stick is spiral-shaped to maximise contact with the teeth.
As the dog chews, a soft centre is released, which targets the bacteria which causes bad breath and plaque.
Dental Care Sticks are available in three sizes.
Jayne Laycock, Vet in Residence at Yumove said: “Poor dental health affects around 80% of the dog population and is the most commonly reported problem in primary care vet practices.
"We know that less than 50% of dog owners use a dental product as regularly as they should.
"Yumove Dental care sticks can be easily incorporated into a dog’s existing routine and have been developed to clean teeth, tackle bad breath and through our ActivBarrier technology, support the balance of bacteria in a dog’s mouth - helping to maintain healthy gums and teeth.”
YuMOVE Dental Care Sticks start at £10.
www.yumove.co.uk
Vygon Vet has launched a procedural custom pack service.
Vygon Vet's procedural custom packs contain all the single-use devices required for a specific procedure enclosed within a sterile wrap. Components available include draping material, theatre clothing, swabs, kidney dishes, forceps etc. Vygon Vet says the service has been developed to reduce infection risks, but also to help manage staff resources more effectively and identify total procedure costs for billing purposes.
The first custom pack is now being used by the team of clinicians at Charter Veterinary Hospital. Dave Tittle BVetMed MRCVS said "The pack contains everything we need, designed to our specification, and will save us theatre preparation time and added expense".
A number of customers have committed themselves to the new service and by the end of 2010 Vygon Vet aims to have many more practices on board. The custom pack service supports Vygon Vet's range of theatre draping packs already available.
For more information, visit www.vygonvet.co.uk
Following last year's campaign, Merial commissioned a survey to learn more about how horse owners seek and receive information about the wider aspects of preventative healthcare, and in particular about the relationship with their veterinary practice.
In the survey of 455 horse owners, which was carried out by CMI Research, 78% said their veterinary surgeon was the most important source of information. The next most important influencers were yard managers/grooms at just 22%.
Louise Radford MRCVS from Merial said: "We wanted to learn more about client education and the opportunities for practices to get more from their client relationships, including vaccination and booster uptake. However we hadn’t estimated just how much horse owners rely on their vet for information!"
"However there appears to be a significant gap between vets as a source of information, and their client’s purchasing habits. Health plans are a great example of the potential for improved compliance, with benefits to the horse, client and practice. Yard health plans present an opportunity to increase booster uptake and also to include animals that might not otherwise be vaccinated.
"Of those horse owners and grooms surveyed who did not vaccinate some or all of their horses, their reasons included horses that never leave the yard, or are old, young, or do not interact with other horses. Yet we know that horses that don’t travel are still at risk of equine flu, as virus can travel up to a mile as an aerosol on the wind, in addition to being carried on objects such as buckets and tack.
"So as the key influencers on preventative healthcare, there is much that practices can do to further engage with clients to increase uptake of products and services, improve client loyalty, and ultimately boost the practice business."
For more information on Equine Flu Awareness Month- 2017, including client materials and video content, visit www.equinefluawareness.com
During the course, which counts as 7 CPD hours, some of the best-known veterinary experts in equine nutrition will be sharing their knowledge with the speaker panel comprising Caroline Argo, Andy Durham, Pat Harris, Nicky Jarvis and Sarah Stoneham.
Course organiser Nicky Jarvis said: "Whether it's a conversation with an owner about their overweight horse, examining a geriatric pony with weight loss or formulating nutrition for an orphan foal, tailored nutrition is the cornerstone of every equine case we see in veterinary practice.
"We regularly treat a variety of conditions such laminitis and colic, but are we always confident about the best feeding advice to give our clients? And how often do we walk into a tack room full of the ‘latest’ supplements and wonder if any of them actually work?"
The course will look at a range of clinical conditions to enable vets to build evidence-based feeding advice into their treatment plans, formulate diets for any age of horse and see which supplements are worth the internet hype. The speakers will provide practical tips for everything from the anorexic pony to the stubborn weight loss case.
The course will cover how to:
BEVA President Lucy Grieve said: "Following the National Equine Forum’s Great Weight Debate (Equine) last month, appropriate equine nutrition has never been more topical.
"Equine obesity is a growing problem and this debate has highlighted how teamwork, communication and trust will help to tackle it to best effect. Veterinary professionals are in a unique and privileged position to support owners on all matters of nutrition and this course will give you the knowledge you need to provide practical, constructive help."
From superfoods to supplements: How to know more than the owner will cost £80.00 for members and £160.00 for non-members. To find out more and to book visit https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/555
The ISFM says Congress will offer veterinary professionals an extensive scientific programme designed to support a multi-modal and cat friendly approach to caring for feline patients with acute upper urinary tract disease and other emergencies.
Speakers will include Søren Boysen (Emergency & Critical Care), Serge Chalhoub (Internal Medicine), Laura Owen (Soft Tissue Surgery) and special guest Allyson Berent (Non-Invasive Surgery).
Sam Taylor MRCVS, ISFM Veterinary Specialist Lead (pictured right) said: "We seem to be seeing more and more feline urinary cases, urolithiasis and acute kidney injury - and of course the familiar blocked cats!
"In Dublin, I can’t wait to hear how to approach these cases as well as look more in-depth at ECC and discuss cat friendly critical care amongst many other topics from all angles – surgery, medicine, behaviour, imaging and more!’
The 2023 ISFM Feline Congress Dublin is open to veterinary surgeons and nurses of all experience levels.
https://icatcare.org/congress-2023-dublin/
Petplan has announced the finalists for the 2011 Petplan Veterinary Awards.
Now in its 12th year, the Petplan Veterinary Awards received its biggest response yet with over 2,800 nominations submitted for exceptional veterinary staff all over the UK.
The finalists for each of the categories are as follows:
Vet of the YearCharles Bagnal, Orwell Veterinary Group - Ipswich Alison Laurie, Crown Vets - Highlands Daniel Parry, Village Vet Garden Suburb - London
Vet Nurse of the YearEmma Clare, Copthorne Veterinary Clinic - Shropshire Maria Corcoran, Orwell Veterinary Group - Ipswich Ingrid Hunt, Cranbrook Veterinary Centre - Devon
Support Staff of the YearBev Millward, Milton Keynes Veterinary Group - Milton KeynesLauren Hunter, The Ferns Veterinary Practice - Dunkeld Patty Fraser, Loch Leven Equine Practice - Kinross
Vet Practice of the YearAshfield House Veterinary Hospital Ltd - Nottinghamshire Emersons Green Veterinary Surgery Ltd - Avon Leonard Brothers Veterinary Centre Ltd - Shropshire
Alison Andrew, Petplan's Marketing Manager, said: "The nominations get bigger and better every year and we're absolutely delighted to announce the finalists for 2011. With 70% of veterinary practices within 3 miles of their patients, veterinary staff are an important part of the community and that's why we feel it important that they have a chance to receive the recognition they deserve. We're looking forward to revealing the winners on 31st of March."
All finalists will be invited to an elegant awards ceremony that will take place on 31st March at the Birmingham Town Hall, where the winners will be announced.
For further information, visit http://www.petplanvet.co.uk/
Vetbromide is presented as a 600mg double divisible tablet for both large and small dogs, and for greater flexibility with dose titration. Tablets are blister packed for ease of storage and dispensing, with a four-year unopened shelf life.
Alongside the launch, TVM has prepared a range of product support materials, including: product guidelines, treatment and monitoring guidelines, seizure management ‘lunch and learn’ sessions, and pet owner information.
TVM has also created a free e-learning tool which takes veterinary staff through the process of diagnosing, treating and monitoring dogs with suspected epilepsy.
Will Peel, product manager at TVM said: "The addition of Vetbromide to our epilepsy range allows vets more flexibility when treating epileptic patients. To further assist vets, we are also offering a wide range of free literature and in-practice support to ensure that veterinary staff are up to speed on such a common, yet at times complicated, topic.’
For more information, visit www.tvm-uk.com/epilepsy, or contact your TVM UK Territory Manager.
The one day course for general practitioners will be presented by Dr Sonya Miles, an RCVS Recognised Advanced Practitioner in Zoological Medicine and lead clinician for Highcroft Exotic Vets (an RWAF Gold accredited practice).
It's worth 7.5hrs of CPD. Sonya will be covering:
This course costs £250 and includes lunch, tea/coffee/biscuits, and a certificate of completion.
Apparently there are acres of parking. For those not able to attend, www.justexotics.co.uk has an extensive library of free content including: fact sheets, care sheets, protocols and “How to” videos covering exotic mammals, reptiles, birds, amphibians, fish, invertebrates and British wildlife, as well as a constantly expanding catalogue of webinars covering these species.
Equine vets and farriers in South Wales who need horses x-rayed can now use a new mobile service offered by Equiray. Operating 24 hours a day, 7 days a week, Equiray's technicians travel to the site to take digital x-rays, using state-of-the-art imaging equipment.
At the heart of Equiray's service is the Uno Equine portable digital x-ray system; the only system in the world that has a capture screen built into the generator. All images taken can be viewed within minutes and decisions made there and then regarding further tests. The x-ray images are emailed to the veterinary surgeon immediately, or supplied to the practice on a CD or memory stick. They are also stored securely by Equiray for a 3 month period.
For farriers, the image can be displayed on screen so they can see the internal bone structures encapsulated within the hoof before they start remedial work, and then another x-ray taken after the work has been completed. Both images can be viewed together for comparison.
Equiray says its service means practices don't have to buy and maintain costly equipment, nor send a practice technician to attend with the vet, as all Equiray technicians are highly skilled in equine imaging.
Equiray currently operates mainly in South Wales but with requests coming from other areas of the country, the company says its technicians are travelling to x-ray several horses in a particular area, over a 2 day period. Remedial farriers requiring monthly x-rays of certain horses are also using the service and plans to extend the service nationally are in progress.
For more information, visit www.equiray.co.uk/
At the outset of the hearing, which was to consider evidence for a number of charges relating to the treatment of three colts at his former practice in 2015, Mr Denny made an application to the Committee that the hearing should be adjourned contingent on a form of undertakings being accepted. These undertakings were that his name be removed from the Register with immediate effect and that he never apply to be restored to the Register under any category.
The application was granted by the Committee, taking into account a number of factors. These include the fact that Mr Denny had now retired and closed his practice, his long and hitherto unblemished veterinary career and the fact that it would not be proportionate, or in the public interest, for there to be a lengthy hearing on the matter.
The Committee noted that there were several precedents for concluding cases in such a manner. The Committee also noted that the application was supported by both the College and the complainant.
Mr Denny was removed from the Register as of Monday 24 April 2017.
Purina says the foods contain adjusted and graded levels of protein and phosphorus to address the delicate balance of providing needed protein in older cats against uraemic toxin production in late phase renal decline.
The current advice is that phosphate should be restricted when the renal patient has confirmed CKD, and IRIS provides therapeutic serum phosphate targets for each stage.
Dr Ellie Groves BA(Hons) VetMB MRCVS, Purina Technical Manager for the UK and Ireland, said: “As obligate carnivores, cats have a high requirement for protein, however, around 20% of senior cats have decreased ability to digest protein, and so are absorbing less protein.
"An inadequate intake of protein leads to loss of lean body mass as muscle is catabolised to meet this need.
"We know that this loss of lean body mass is significantly correlated with an increased risk of mortality.
"But we need to be careful – in renal disease, there is the potential for protein breakdown products to increase in the circulation, acting as toxins.
"So, we need to fine-tune the amount of protein, depending on the stage of chronic renal insufficiency (CRI).
"A dual approach, with Early and Advanced products, allows tailoring of protein levels.”
“Alongside protein, phosphorus content is also tailored to the stage of kidney decline.
"Restricting phosphorus can slow the progression of chronic kidney disease by reducing morphological damage to the kidneys and is thought to be the most important influencer of survival in cats with CKD.
"The levels of phosphorus in the products, are tailored, alongside the protein, to reflect the needs of the cat, with increased restriction when cats are in advanced decline and the kidneys are struggling most.”
NF Renal Function Early Care is available in a dry format (1.5kg) and a pouch (tender pieces with chicken 85g).
NF Renal Function Advanced Care is available in 1.5kg and 5kg packs of dry food, and ‘wet’ options of tender pieces with chicken/ salmon (85g pouches) and a mousse (195g can).
Both diets are now available in veterinary wholesalers.